🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Asian Stocks Mostly Down, China Releases Mixed Export and Import Data

Published 09/06/2020, 11:18 PM
Updated 09/06/2020, 11:27 PM
© Reuters.
AXJO
-
JP225
-
HK50
-
CSL
-
KS11
-
AZN
-
SSEC
-
SZI
-

By Gina Lee

Investing.com – Asian stocks were mostly down on Monday morning, with markets slowly recovering from the biggest two-day slide since June and investors digesting data released by China.

China’s Shanghai Composite inched down 0.09% by 11:20 PM ET (4:20 AM GMT) and the Shenzhen Component fell 1.10%. The country released mixed export and import data for August earlier in the day, with exports up 9.5% year-on-year from July’s 7.2% increase but imports down 2.1% year-on-year, more than July’s 1.4% fall. The trade balance decreased to $58.93 billion, down from the previous month’s $62.33 billion.

Japan’s Nikkei 225 edged down 0.18%, ahead of a slew of economic data to be released on Tuesday, including figures on household spending, the current account and the gross domestic product.

Some investors also expected more stimulus measures before the end of the year and expected incumbent prime minister Shinzo Abe’s Abenomics policy to be continued by his replacement.

Hong Kong’s Hang Seng Index edged up 0.19%, reversing its earlier losses. Police reportedly made 289 arrests in the aftermath of protests that took place in the city on Sunday, the original date of the Legislative Council elections. The elections have been postponed to 2021 due to COVID-19.

South Korea’s KOSPI rose 0.64%.

Australia’s ASX 200 inched down 0.02%. Australian biotechnology company CSL Ltd (ASX:CSL) said earlier in the day that it would manufacture a COVID-19 vaccine candidate being developed by AstraZeneca (NYSE:AZN) and Oxford University upon the completion of successful trials. The first doses for Australian are expected by early 2021.

CSL will also develop a second vaccine candidate, which it is developing alongside the University of Queensland, with the first doses also expected by mid-2021.

But some investors remained cautious over the global recovery from Thursday’s slide.

“Risk assets remain fragile following Thursday’s tech-led rout and volatility spike … with stimulus having been key for supporting equities and such lofty valuations, its renewal will be crucial not only for the recovery, but as a driver for equities as job risks mount,” Medley Global Advisors managing director for global macro strategy Ben Emons told Bloomberg.

Meanwhile, U.S. Treasury Secretary Steven Mnuchin on Sunday said a deal between the White House and Congress would finalize details on a spending bill by the end of the week and fund the federal government through the beginning of December, boosting investor hopes that a shutdown will be averted.

Mnuchin and U.S. House Speaker Nancy Pelosi have reportedly agreed to extend funding, with the measure set to avert a government shutdown when current funding dries up at the end of the month.

“We’re going to move forward with a clean continuing resolution, hopefully through the beginning of December,” Mnuchin said adding: “I hope by the end of the week we’ll have something firmed up.”

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.